ARCHIVES

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 23 | June 9, 1995

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Renew By NCI Gets Under Way

May 3, 1985

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

In Brief: Breast Cancer Diet Study Problems Resolved, Funding Resumed For Nutrition Coordinator

April 19, 1985

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992